Tag: obesity
The Top 10 Health Care Stories of 2010
by Melly Alazraki on Dec.29, 2010, under Towing
Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the biggest health care stories.
Continue reading The Top 10 Health Care Stories of 2010
The Top 10 Health Care Stories of 2010 originally appeared on DailyFinance on Wed, 29 Dec 2010 07:30:00.
Filed Under: Health Care, Genzyme Corporation , Johnson & Johnson, Pfizer, Sanofi Aventis, Merck, GlaxoSmithKline, Novartis, Abbott, Astrazeneca
Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year
by Melly Alazraki on Oct.29, 2010, under Towing
Vivus shares are soaring this morning, even though the U.S. Food and Drug Administration rejected the drugmaker’s obesity drug Qnexa yesterday. Investors are hoping that the FDA’s rejection, which includes a request for more safety data — not another clinical trial — will lead to approval next year.
Continue reading Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year
Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year originally appeared on DailyFinance on Fri, 29 Oct 2010 11:10:00.
Filed Under: Company News, Health Care, Stocks in the News
Former McDonald’s Manager Not Lovin’ His Weight Gain
by Danny King on Oct.28, 2010, under Towing
McDonald’s has lost a $17,500 lawsuit from a former franchise manager in Brazil, who says he put on 65 pounds during his 12 years of working for the chain. The former employee blames the company’s policy of mandatory food sampling and free employee lunches for his weight gain.
Continue reading Former McDonald’s Manager Not Lovin’ His Weight Gain
Former McDonald’s Manager Not Lovin’ His Weight Gain originally appeared on DailyFinance on Thu, 28 Oct 2010 19:00:00.
Filed Under: Company News, McDonald’s, Retail
Abbott Pulls Weight Loss Drug Meridia from the Market
by Melly Alazraki on Oct.08, 2010, under Towing
Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.
Continue reading Abbott Pulls Weight Loss Drug Meridia from the Market
Abbott Pulls Weight Loss Drug Meridia from the Market originally appeared on DailyFinance on Fri, 08 Oct 2010 16:14:00.
Filed Under: Company News, Health Care, Abbott, Stocks in the News
Why Americans Lag in Life Expectancy — Even as Health Care Spending Soars
by Melly Alazraki on Oct.07, 2010, under Towing
A new study from Columbia University finds that the reasons America is lagging other countries aren’t the commonly cited obesity, smoking, traffic fatalities and homicide. Rather, the problem has been poor health care, or rather, a poor health care system.
Continue reading Why Americans Lag in Life Expectancy — Even as Health Care Spending Soars
Why Americans Lag in Life Expectancy — Even as Health Care Spending Soars originally appeared on DailyFinance on Thu, 07 Oct 2010 12:50:00.
Filed Under: Economy, Health Care







